Ifupinostat Hydrochloride
Tier C — Watch / tradeIfupinostat Hydrochloride
Targets：Class I PI3K, HDAC
Indications (approved)：Diffuse large B-cell lymphoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| BEBT-908 | 1646906-27-5 | N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide trihydrochloride |
| BEBT-908-001 | 22288-78-4 | methyl 3-aminothiophene-2-carboxylate |
| BEBT-908-002 | 16233-51-5 | thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione |
| BEBT-908-003 | 16234-14-3 | 2,4-dichlorothieno[3,2-d]pyrimidine |
| BEBT-908-004 | 16234-15-4 | 4-(2-chlorothieno[3,2-d]pyrimidin-4-yl)morpholine |
| BEBT-908-005 | 885618-31-5 | 2-chloro-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde |
| BEBT-908-006 | 955979-15-4 | 1-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)-N-methylmethanamine |
| BEBT-908-007 | 89793-12-4Available | ethyl 2-chloropyrimidine-5-carboxylate |
| BEBT-908-008 | 1235450-25-5 | ethyl 2-(((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate |
| BEBT-908-009 | 265664-53-7 | (6-(methylamino)pyridin-3-yl)boronic acid hydrochloride |
| BEBT-908-010 | 1339926-04-3 | ethyl 2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxylate |
| BEBT-908-011 | 1235449-52-1 | N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide |
| BEBT-908-012 | 624-28-2 | 2,5-dibromopyridine |
| BEBT-908-013 | 84539-30-0 | 5-bromo-N-methylpyridin-2-amine |
| BEBT-908-014 | 227939-01-7 | tert-butyl (5-bromopyridin-2-yl)(methyl)carbamate |
Frequently asked questions
What are the approved indications of Ifupinostat Hydrochloride?
Approved indications include: Diffuse large B-cell lymphoma.
When does the Ifupinostat Hydrochloride patent expire?
No public expiry year is available for Ifupinostat Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Ifupinostat Hydrochloride?
1 synthesis routes are recorded; the shortest is 12 steps with 10.04 kg (BEBT-908) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Ifupinostat Hydrochloride intermediates?
1 intermediate CAS of Ifupinostat Hydrochloride are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Ifupinostat Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22